BIGtheme.net http://bigtheme.net/ecommerce/opencart OpenCart Templates
Thursday , March 21 2019
Home / biotechnology

biotechnology

The World Health Organization is setting up rules and oversight for human gene editing

The World Health Organization is setting up rules and oversight for human gene editing

Yesterday, the World Health Organization concluded the first meeting of the new Advisory Committee which aims to create global governance and monitoring standards for human genetic editing. Last December, a Chinese scientist genetically modified two embryos using CRISPR technology (19459003) to remove the CCR5 gene. The committee hurriedly summoned the ...

Read More »

XGenomes is bringing DNA sequencing to the masses

XGenomes is bringing DNA sequencing to the masses

As healthcare shifts to gene-customized treatment, one of the biggest obstacles to truly personalized medicine is the lack of rapid, low-cost genetic testing. Few people are more familiar with Karim Mill than the problem of today's genetic diagnostic tools. He is the founder of the 52-year-old XGenomes who has been ...

Read More »

Mammoth Biosciences adds the final piece of the CRISPR diagnostics puzzle to its toolkit

Mammoth Biosciences adds the final piece of the CRISPR diagnostics puzzle to its toolkit

announced today Mammoth Biosciences has received an exclusive license from the University of California at Berkeley for the new CRISPR protein Cas14, which now has the latest diagnostic kit location. Cas14 is a newly discovered protein from the Jennifer Doudna laboratory. Jennifer Doudna is a pioneer in gene editing research ...

Read More »

With $90 million in funding, the Ginkgo spinoff Motif joins the fight for the future of food

With $90 million in funding, the Ginkgo spinoff Motif joins the fight for the future of food

Continue to seek to become Amazon Web Service for the manufacture of creatures, <a href = "http: / /ginkgobioworks .com/">Ginkgo Bioworks has launched a new derivative called Motif Ingredients which is worth $90 million to develop protein that can be used as a substitute for meat and dairy products. . ...

Read More »

J&J spends $3.4 billion in cash for Auris Health’s lung cancer diagnostics and surgical robots

Crypto’s second bubble, Juul has 60 days and three Chinese IPOs

Johnson & Johnson's Robotic Surgery and Medical Devices Division, Ethicon is raising $3.4 billion in cash for receiving Auris Health Developers initially focused on robotic diagnostics and surgical devices for detecting and treating lung cancer. The health care giant said that if Auris encounters certain milestones, it may pay an ...

Read More »

Two former members of Google’s skunkworks division have launched a biomanufacturing company

Two former members of Google’s skunkworks division have launched a biomanufacturing company

Bio-manufacturing technology – using a modified version of the existing creature and bending it into the human will – has transformed from a sci-fi world to a new reality. In the field of entrepreneurship, companies are beginning to produce synthetic spider silk, or to make leather substitutes, meat substitutes, or ...

Read More »

Driving down the cost of preserving genetic material, Acorn Biolabs raises $3.3 million

Driving down the cost of preserving genetic material, Acorn Biolabs raises $3.3 million

Acorn Biolabs wants consumers to pay for genetic material to ensure that advances in targeted gene therapy will lead to better health outcomes. The company's goal is to "save young cells today, live longer, better, and tomorrow." This is a gamble on the cutting edge of healthcare technology that has ...

Read More »

Up to $818 million deal between J&J and Locus Biosciences points to a new path for CRISPR therapies

Up to $818 million deal between J&J and Locus Biosciences points to a new path for CRISPR therapies

announced today {18459002} Locus Biosciences and Janssen Pharmaceuticals (a division of Johnson & Johnson) reached a $816 million transaction pointing to the new way of editing the CRISPR gene And (possibly) the entire microbiome targeted therapeutic field. Locus is headquartered in the Triangle Research Park in North Carolina and is ...

Read More »

Sophia Genetics bags $77M Series E, with 850+ hospitals signed up to its “data-driven medicine”

Sophia Genetics bags $77M Series E, with 850+ hospitals signed up to its “data-driven medicine”

Another considerable cash injection of big data biotechnology: Sophia Genetics announced a $77 million Series E round of financing, since the company's inception in 2011, its total funding The amount has increased to 140 million US dollars. The company applied AI to DNA sequencing to achieve the title of "data-driven ...

Read More »

Companies tracking mutations in cancer cells can provide a key to unlocking better therapies

Companies tracking mutations in cancer cells can provide a key to unlocking better therapies

Investors and entrepreneurs are beginning to introduce new diagnostic tools to the market to identify cancer cells that can create more targeted therapies, resulting in better outcomes for cancer patients. Earlier this month, studies using techniques developed by the startup Mission Bio helped identify cell mutations in acute myeloid leukemia ...

Read More »